Structures by: Aiyub Z.
Total: 19
2-(4-Chloroanilino)pyridine
C11H9ClN2
Acta Crystallographica Section E (2008) 64, 9 o1800
a=7.3926(3)Å b=15.3577(5)Å c=17.6093(6)Å
α=73.723(2)° β=87.360(3)° γ=87.128(3)°
N-(pyrazin-2-yl)aniline
C10H9N3
Acta Crystallographica Section E (2008) 64, 11 o2105
a=11.0644(3)Å b=7.8423(3)Å c=10.8907(3)Å
α=90.00° β=116.439(2)° γ=90.00°
<i>N</i>-(Pyrimidin-2-yl)aniline
C10H9N3
Acta Crystallographica Section E (2009) 65, 4 o703
a=8.8792(2)Å b=9.9382(2)Å c=10.2038(2)Å
α=93.1860(10)° β=103.6650(10)° γ=97.7800(10)°
4-Chloro-<i>N</i>-(2-pyridyl)aniline
C11H9ClN2
Acta Crystallographica Section E (2008) 64, 12 o2437
a=15.5096(4)Å b=7.5519(2)Å c=17.6846(4)Å
α=90.00° β=106.284(2)° γ=90.00°
<i>N</i>-(3-Methylphenyl)pyrimidin-2-amine
C11H11N3
Acta Crystallographica Section E (2010) 66, 9 o2446
a=9.4461(10)Å b=10.0946(11)Å c=11.6266(13)Å
α=80.4010(10)° β=82.745(2)° γ=66.0050(10)°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis{[4-methyl-<i>N</i>-(4- methylphenyl)pyridin-2-amine-κ<i>N</i>^1^]copper(II)}
C34H40Cu2N4O8
Acta Crystallographica Section E (2010) 66, 9 m1077-m1078
a=11.7519(6)Å b=15.5822(8)Å c=9.9050(5)Å
α=90° β=110.5698(6)° γ=90°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis{[<i>N</i>-(4-chlorophenyl)-4- methylpyridin-2-amine-κ<i>N</i>^1^]copper(II)}
C32H34Cl2Cu2N4O8
Acta Crystallographica Section E (2010) 66, 9 m1049-m1050
a=11.7430(17)Å b=15.619(2)Å c=9.9866(14)Å
α=90° β=109.901(2)° γ=90°
<i>N</i>-(Pyrazin-2-yl)-4-toluidine
C11H11N3
Acta Crystallographica Section E (2008) 64, 12 o2440
a=21.7179(7)Å b=7.5323(3)Å c=12.0073(5)Å
α=90.00° β=105.790(3)° γ=90.00°
<i>N</i>-(2-Pyridyl)-4-toluidine
C12H12N2
Acta Crystallographica Section E (2008) 64, 12 o2441
a=18.2260(7)Å b=10.5680(3)Å c=10.6005(3)Å
α=90.00° β=95.364(2)° γ=90.00°
4-Chloro-<i>N</i>-(pyrazin-2-yl)aniline
C10H8ClN3
Acta Crystallographica Section E (2009) 65, 1 o113
a=12.1257(3)Å b=3.79440(10)Å c=19.7242(5)Å
α=90.00° β=91.370(2)° γ=90.00°
<i>N</i>-(Quinoxalin-2-yl)-4-toluidine
C15H13N3
Acta Crystallographica Section E (2009) 65, 1 o93
a=12.2081(9)Å b=11.3720(9)Å c=35.097(3)Å
α=90.00° β=90.00° γ=90.00°
2-(3-Chloroanilino)pyridine
C11H9ClN2
Acta Crystallographica Section E (2009) 65, 6 o1449
a=3.89540(10)Å b=10.7804(4)Å c=12.4548(4)Å
α=64.932(2)° β=88.004(2)° γ=88.240(2)°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis{[2-(<i>m</i>-tolylamino)pyridine- κ<i>N</i>]copper(II)}
C32H36Cu2N4O8
Acta Crystallographica Section E (2009) 65, 12 m1690
a=7.7143(2)Å b=10.5625(3)Å c=11.2413(3)Å
α=66.531(2)° β=85.740(2)° γ=78.568(2)°
<i>N</i>-(4-Methyl-2-pyridyl)-<i>p</i>-toluidine
C13H14N2
Acta Crystallographica Section E (2010) 66, 2 o371
a=10.9385(11)Å b=7.5708(8)Å c=13.4372(14)Å
α=90.00° β=95.246(2)° γ=90.00°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis{[4-methyl-2-(<i>m</i>- tolylamino)pyridine-κ<i>N</i>]copper(II)}
C34H40Cu2N4O8
Acta Crystallographica Section E (2010) 66, 2 m165
a=8.2489(4)Å b=14.2110(7)Å c=16.4484(8)Å
α=107.7980(10)° β=101.9710(10)° γ=97.6610(10)°
<i>N</i>-(4-Chlorophenyl)-4-methylpyridin-2-amine
C12H11ClN2
Acta Crystallographica Section E (2010) 66, 8 o2186
a=15.9335(15)Å b=4.0651(4)Å c=17.0153(16)Å
α=90° β=98.7550(10)° γ=90°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis[(<i>N</i>-ethylpyrimidin-2- amine)copper(II)](<i>Cu</i>—–-<i>Cu</i>)
C20H30Cu2N6O8
Acta Crystallographica Section E (2010) 66, 9 m1181
a=7.8488(6)Å b=8.5114(7)Å c=10.2999(8)Å
α=98.4040(10)° β=92.6980(10)° γ=105.5990(10)°
N-(4-Methyl-2-pyridyl)-m-toluidine
C13H14N2
Acta Crystallographica Section E (2011) 67, 11 o3078
a=7.1802(9)Å b=7.6509(10)Å c=10.8120(14)Å
α=106.957(2)° β=91.859(2)° γ=95.720(2)°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis{[<i>N</i>-(4- methylphenyl)pyridin-2-amine-κ<i>N</i>^1^]copper(II)}(<i>Cu</i>—–-<i>Cu</i>)
C32H36Cu2N4O8
Acta Crystallographica Section E (2011) 67, 11 m1636
a=7.6285(9)Å b=11.3242(13)Å c=18.566(2)Å
α=90.00° β=95.717(2)° γ=90.00°